Insight Molecular Diagnostics Inc. (IMDX) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $394.94M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $67.00K; Retained Earnings (Accumulated Deficit)USD $-416.31M.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $394.29M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $71.00K; Retained Earnings (Accumulated Deficit)USD $-405.05M.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $369.21M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $86.00K; Retained Earnings (Accumulated Deficit)USD $-400.76M.
- 2025-09-30: Preferred Stock, Value, IssuedUSD (m); Common Stock, Value, IssuedUSD $368.52M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $86.00K; Retained Earnings (Accumulated Deficit)USD $-377.81M.
Insight Molecular Diagnostics Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Additional Paid in Capital, Common Stock USD |
|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $394.94M | $67.00K | $-416.31M | $-21.30M | (m) |
| 2026-03-31 | $0.00 | $394.29M | $71.00K | $-405.05M | $-10.69M | (m) |
| 2025-12-31 | $0.00 | $369.21M | $86.00K | $-400.76M | $-31.46M | (m) |
| 2025-09-30 | (m) | $368.52M | $86.00K | $-377.81M | $-9.20M | (m) |
| 2025-06-30 | (m) | $367.96M | $85.00K | $-366.95M | $1.10M | (m) |
| 2025-03-31 | (m) | $367.39M | $41.00K | $-357.21M | $10.22M | (m) |
| 2024-12-31 | $0.00 | $338.24M | $21.00K | $-350.54M | $-12.27M | (m) |
| 2024-09-30 | (m) | $326.68M | $57.00K | $-317.03M | $9.71M | (m) |
| 2024-06-30 | (m) | $326.20M | $37.00K | $-303.54M | $22.70M | (m) |
| 2024-03-31 | (m) | $310.55M | $40.00K | $-299.00M | $11.59M | (m) |
| 2023-12-31 | (m) | $310.30M | $49.00K | $-289.88M | $20.47M | (m) |
| 2023-09-30 | (m) | $310.00M | $32.00K | $-262.10M | $36.14M | (m) |
| 2023-06-30 | (m) | $309.54M | $41.00K | $-262.10M | $43.60M | (m) |
| 2023-03-31 | (m) | $295.53M | $43.00K | $-262.10M | $37.93M | (m) |
| 2023-01-01 | (m) | (m) | (m) | $1.40M | (m) | (m) |
| 2022-12-31 | (m) | $294.93M | $39.00K | $-260.68M | $34.29M | (m) |
| 2022-09-30 | (m) | $292.54M | $19.00K | $-215.70M | $76.86M | (m) |
| 2022-06-30 | (m) | $289.65M | $31.00K | $-206.44M | $83.24M | (m) |
| 2022-03-31 | (m) | $254.99M | $38.00K | $-198.06M | $56.97M | (m) |
| 2021-12-31 | (m) | $252.95M | $37.00K | $-187.77M | $65.22M | (m) |
| 2021-09-30 | (m) | $251.24M | (m) | $-151.89M | $99.35M | (m) |
| 2021-06-30 | (m) | $240.75M | (m) | $-138.09M | $102.67M | (m) |
| 2021-03-31 | (m) | $234.22M | (m) | $-127.60M | $106.63M | (m) |
| 2021-02-28 | (m) | (m) | (m) | (m) | (m) | $69.60K |
| 2020-12-31 | (m) | $157.16M | (m) | $-123.68M | $33.48M | (m) |
| 2020-09-30 | (m) | $152.01M | (m) | $-117.37M | $34.64M | (m) |
| 2020-06-30 | (m) | $150.18M | (m) | $-110.58M | $39.59M | (m) |
| 2020-03-31 | (m) | $138.10M | (m) | $-101.48M | $36.62M | (m) |
| 2019-12-31 | (m) | $124.58M | (m) | $-93.75M | $30.84M | (m) |
| 2019-09-30 | (m) | $115.13M | (m) | $-85.79M | $29.34M | (m) |
| 2019-06-30 | (m) | $114.07M | (m) | $-80.57M | $33.51M | (m) |
| 2019-03-31 | (m) | $113.37M | (m) | $-75.18M | $38.19M | (m) |
| 2018-12-31 | (m) | $74.74M | (m) | $-71.32M | $3.42M | (m) |
| 2018-09-30 | (m) | $74.34M | (m) | $-66.82M | $7.52M | (m) |
| 2018-06-30 | (m) | $70.69M | (m) | $-63.85M | $6.85M | (m) |
| 2018-03-31 | (m) | $68.37M | (m) | $-59.34M | $9.02M | (m) |
| 2017-12-31 | $0.00 | $59.97M | $-888.00K | $-54.68M | $4.40M | (m) |
| 2017-09-30 | $0.00 | $59.41M | $-645.00K | $-50.72M | $8.05M | (m) |
| 2017-06-30 | $0.00 | $49.98M | $-535.00K | $-43.81M | $5.64M | (m) |
| 2017-03-31 | $0.00 | $49.36M | $-581.00K | $-40.01M | $8.77M | (m) |
| 2016-12-31 | $0.00 | $45.82M | $-654.00K | $-35.30M | $9.86M | (m) |
| 2016-09-30 | $0.00 | $45.35M | $-474.00K | $-32.20M | $12.68M | (m) |
| 2016-06-30 | $0.00 | $35.34M | $-1.27M | $-29.61M | $4.47M | (m) |
| 2016-03-31 | $0.00 | $35.07M | $-1.11M | $-27.06M | $6.89M | (m) |
| 2015-12-31 | $0.00 | $34.90M | $-350.00K | $-24.13M | $10.42M | (m) |
| 2014-12-31 | (m) | (m) | (m) | (m) | $-1.07M | (m) |
| 2013-12-31 | (m) | (m) | (m) | (m) | $3.62M | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |